SCHEMBL3658322

SCHEMBL3658322

Cc1ccc(-c2cc(C(=O)O)cc(C3(C(F)(F)F)N=NN=N3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.44
CTRC Q99895 1/20 0.43
RXRA P19793 3/20 0.41
RXRB P28702 3/20 0.41
RXRG P48443 1/20 0.41
KIF11 P52732 1/20 0.41
P2RY14 Q15391 2/20 0.40
FABP1 P07148 1/20 0.40
AURKA O14965 1/20 0.39
TPX2 Q9ULW0 1/20 0.39
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
SRD5A2 P31213 1/20 0.37
MAP4K4 O95819 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655842 0.86 KIF11 (0.41) KIF11ALDH1A1KDM4EGAAMAPT
SCHEMBL3657018 0.81 DHODH (0.48) DHODHCTRCRXRARXRBP2RY14
SCHEMBL4054516 0.81 KIF11 (0.37) KIF11
SCHEMBL3659205 0.79 DHODH (0.46) DHODHCTRCRXRARXRBP2RY14
SCHEMBL3660070 0.78 DHODH (0.45) DHODHCTRCRXRARXRBP2RY14
SCHEMBL3660906 0.76 DHODH (0.43) DHODHCTRCRXRARXRBP2RY14
SCHEMBL30810730 0.74 KIF11 (0.53) KIF11NPC1RAB9ASMN1; SMN2
SCHEMBL1495453 0.73 DHODH (0.70) DHODHCTRCRXRARXRBP2RY14
SCHEMBL16196117 0.73 DHODH (0.70) DHODHCTRCRXRARXRBP2RY14
SCHEMBL16875749 0.72 DHODH (0.39) DHODHCTRCRXRARXRBP2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed
EP-2038264-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000645-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed